Richard Pizzi is editor of The Hospitalist. He has been an editor at Frontline Medical Communications since 2015, and previously served as editor of MDedge publications Hospitalist News and ID Practitioner. He has also worked as an editor and in editorial management roles for HIMSS Media, MedTech Media, and the American Association for Clinical Chemistry. Follow him on Twitter @richpizzi
The antiretroviral drug abacavir was associated with a more than twofold increased risk of cardiovascular disease in a cohort study of 8,154 HIV-infec...
Switching HIV-infected South African children from ritonavir-boosted lopinavir (LPV/r) to efavirenz (EFV)-based antiretroviral therapy improved bone m...
A great volume of HIV and AIDS research enters the medical literature every month. It’s difficult to monitor everything, so here’s a quick look at som...
Cardiovascular, surgery, and pneumonia patients at hospitals with a fully electronic health record (EHR) system experienced lower rates of in-hospital...
When faced with an outbreak of the extensively drug-resistant pathogen Acinetobacter baumannii (XDR-Ab), hospitals must improve their patient screenin...
A great volume of HIV and AIDS research enters the medical literature every month. It’s difficult to monitor everything, so here’s a quick look at som...
Ninety percent of patients in a 1981 hepatitis B vaccine trial still had evidence of immune protection 30 years later, according to a study in the Jou...
The struggle to defeat Ebola virus disease continues globally, although it may not always make the headlines. To catch up on what you may have missed,...
Two recent research letters from Colombia offer U.S. clinicians insight into the challenges of battling Zika virus on the front lines of the growing p...
The U.S. Food and Drug Administration has approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatiti...
The World Health Organization has failed to act decisively in response to the growing the Zika virus outbreak, global health experts said in a JAMA vi...
Clinical trial results for direct-acting antivirals against hepatitis C virus (HCV) may have limited generalizability for patients coinfected with HIV...
An algorithm that accurately estimates the population-level incidence of hepatitis C infection may boost public health efforts in high-risk population...
